10-Q Filing

AIM IMMUNOTECH INC. CIK: 946644 Q1 2013

Filing Information

Form Type	10-Q
Accession Number	`0000946644-13-000006`
Period End Date	20130331
Filing Date	20130508
Fiscal Year	2013
Fiscal Period	Q1
XBRL Instance	heb-20130331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 74 Income Statement 11 Cash Flow Statement 54 Comprehensive Income 37

Balance Sheet 74 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value per share	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value per share	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, authorized shares	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, authorized shares	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.21M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.10M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.65M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.59M	USD	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable securities unrestricted	`AvailableForSaleSecuritiesCurrent`	$27.24M	USD	Point-in-time
Marketable securities unrestricted	`AvailableForSaleSecuritiesCurrent`	$21.41M	USD	Point-in-time
Marketable securities restricted	`AvailableforsaleSecuritiesRestrictedCurrent`	$14.50M	USD	Point-in-time
Marketable securities restricted	`AvailableforsaleSecuritiesRestrictedCurrent`	$14.84M	USD	Point-in-time
Common stock, par value (usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Inventories	`InventoryWorkInProcess`	$897.00K	USD	Point-in-time
Common stock, authorized shares	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Common stock, authorized shares	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Inventories	`InventoryWorkInProcess`	$453.00K	USD	Point-in-time
Inventories	`InventoryWorkInProcess`	$453.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseCurrent`	$322.00K	USD	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	166.49M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseCurrent`	$293.00K	USD	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	167.07M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$38.58M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$44.73M	USD	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	166.49M	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	167.07M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$5.13M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$5.29M	USD	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$1.03M	USD	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$1.08M	USD	Point-in-time
Construction in progress	`ConstructionInProgressGross`	$6.81M	USD	Point-in-time
Construction in progress	`ConstructionInProgressGross`	$6.58M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$65.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$65.00K	USD	Point-in-time
Total assets	`Assets`	$51.66M	USD	Point-in-time
Total assets	`Assets`	$57.70M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$2.16M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.67M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.27M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$3.40M	USD	Point-in-time
Margin account loan	`MarginAccountLoanLiability`	$7.05M	USD	Point-in-time
Margin account loan	`MarginAccountLoanLiability`	$7.05M	USD	Point-in-time
Current portion of capital lease	`CapitalLeaseObligationsCurrent`	$43.00K	USD	Point-in-time
Current portion of capital lease	`CapitalLeaseObligationsCurrent`	$46.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$12.65M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$10.03M	USD	Point-in-time
Long-term portion of capital lease	`CapitalLeaseObligationsNoncurrent`	$45.00K	USD	Point-in-time
Long-term portion of capital lease	`CapitalLeaseObligationsNoncurrent`	$55.00K	USD	Point-in-time
Redeemable warrants	`DerivativeLiabilitiesNoncurrent`	$206.00K	USD	Point-in-time
Redeemable warrants	`DerivativeLiabilitiesNoncurrent`	$295.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$10.28M	USD	Point-in-time
Total liabilities	`Liabilities`	$13.00M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, par value $0.01 per share, authorized 5,000,000; issued and outstanding; none	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.01 per share, authorized 5,000,000; issued and outstanding; none	`PreferredStockValue`	-	USD	Point-in-time
Common stock, par value $0.001 per share, authorized 350,000,000 shares; issued and outstanding 167, 074,114 and 166,490,190, respectively	`CommonStockValue`	$166.00K	USD	Point-in-time
Common stock, par value $0.001 per share, authorized 350,000,000 shares; issued and outstanding 167, 074,114 and 166,490,190, respectively	`CommonStockValue`	$167.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$288.93M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$288.67M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-43.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-7.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-244.09M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-247.71M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$41.38M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$44.70M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$51.66M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$57.70M	USD	Point-in-time

Income Statement 11 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$41.38M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$44.70M	USD	Point-in-time
Stock issued for settlement of accounts payable	`StockIssuedForSettlementOfAccountsPayable`	$134.00K	USD	1 Quarter
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$36.00K	USD	1 Quarter
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$121.00K	USD	1 Quarter
Net comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-3.58M	USD	1 Quarter
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$41.38M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$44.70M	USD	Point-in-time

Cash Flow Statement 54 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-2.31M	USD	1 Quarter
Net loss	`ProfitLoss`	$-3.61M	USD	1 Quarter
Depreciation of property and equipment	`Depreciation`	$149.00K	USD	1 Quarter
Depreciation of property and equipment	`Depreciation`	$179.00K	USD	1 Quarter
Amortization of patent and trademark rights	`AdjustmentForAmortization`	$4.00K	USD	1 Quarter
Amortization of patent and trademark rights	`AdjustmentForAmortization`	$2.00K	USD	1 Quarter
Redeemable warrants valuation adjustment	`DerivativeGainOnDerivative`	$-151.00K	USD	1 Quarter
Redeemable warrants valuation adjustment	`DerivativeGainOnDerivative`	$89.00K	USD	1 Quarter
Equity-based compensation	`StockOptionPlanExpense`	$36.00K	USD	1 Quarter
Equity-based compensation	`StockOptionPlanExpense`	$121.00K	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	-	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$211.00K	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpense`	$-185.00K	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpense`	$-29.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$775.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-358.00K	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-2.13M	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-444.00K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.67M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-5.85M	USD	1 Quarter
Purchase of property, equipment and construction in progress	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.55M	USD	1 Quarter
Purchase of property, equipment and construction in progress	`PaymentsToAcquirePropertyPlantAndEquipment`	$244.00K	USD	1 Quarter
Additions to patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	-	USD	1 Quarter
Additions to patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$46.00K	USD	1 Quarter
Deposits on capital leases refunded	`PaymentsToAcquireEquipmentOnLease`	-	USD	1 Quarter
Deposits on capital leases refunded	`PaymentsToAcquireEquipmentOnLease`	$-6.00K	USD	1 Quarter
Maturities of short-term and long-term marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$3.19M	USD	1 Quarter
Maturities of short-term and long-term marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$5.53M	USD	1 Quarter
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$1.64M	USD	1 Quarter
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$5.24M	USD	1 Quarter
Payments on capital leases	`RepaymentsOfLongTermCapitalLeaseObligations`	$13.00K	USD	1 Quarter
Payments on capital leases	`RepaymentsOfLongTermCapitalLeaseObligations`	$13.00K	USD	1 Quarter
Proceeds from margin account loan	`ProceedsFromMarginAccountLoan`	$582.00K	USD	1 Quarter
Proceeds from margin account loan	`ProceedsFromMarginAccountLoan`	-	USD	1 Quarter
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$569.00K	USD	1 Quarter
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-13.00K	USD	1 Quarter
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-624.00K	USD	1 Quarter
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$547.00K	USD	1 Quarter
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.21M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$3.10M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$3.65M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.59M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.21M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$3.10M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$3.65M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.59M	USD	Point-in-time
Issuance of common stock for accounts payable and accrued expenses	`IssuanceOfCommonStockForAccountsPayableAndAccruedExpenses`	-	USD	1 Quarter
Issuance of common stock for accounts payable and accrued expenses	`IssuanceOfCommonStockForAccountsPayableAndAccruedExpenses`	$134.00K	USD	1 Quarter
Unrealized gain on marketable securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$36.00K	USD	1 Quarter
Unrealized gain on marketable securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$441.00K	USD	1 Quarter
Redeemable warrants valuation adjustment	`AdjustmentOfWarrantsGrantedForServices`	$-89.00K	USD	1 Quarter
Redeemable warrants valuation adjustment	`AdjustmentOfWarrantsGrantedForServices`	$151.00K	USD	1 Quarter
Cash paid for interest expense and capitalized construction interest	`InterestExpense`	$49.00K	USD	1 Quarter
Cash paid for interest expense and capitalized construction interest	`InterestExpense`	$11.00K	USD	1 Quarter

Comprehensive Income 37 line items

Line Item	Tag	Value	Unit	Period
Clinical treatment programs	`SalesRevenueGoodsNet`	$42.00K	USD	1 Quarter
Clinical treatment programs	`SalesRevenueGoodsNet`	$72.00K	USD	1 Quarter
Total revenues	`Revenues`	$42.00K	USD	1 Quarter
Total revenues	`Revenues`	$72.00K	USD	1 Quarter
Production/cost of goods sold	`CostOfRevenue`	$280.00K	USD	1 Quarter
Production/cost of goods sold	`CostOfRevenue`	$191.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.34M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.67M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.87M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.08M	USD	1 Quarter
Total costs and expenses	`CostsAndExpenses`	$3.82M	USD	1 Quarter
Total costs and expenses	`CostsAndExpenses`	$4.60M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-3.75M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-4.56M	USD	1 Quarter
Interest expense	`InterestExpenseLesseeAssetsUnderCapitalLease`	$5.00K	USD	1 Quarter
Interest expense	`InterestExpenseLesseeAssetsUnderCapitalLease`	$11.00K	USD	1 Quarter
Interest and other income	`OtherInterestAndDividendIncome`	$181.00K	USD	1 Quarter
Interest and other income	`OtherInterestAndDividendIncome`	$273.00K	USD	1 Quarter
Funds received from sale of income tax net operating losses	`FundsReceivedFromSaleOfIncomeTaxNetOperatingLosses`	$1.33M	USD	1 Quarter
Funds received from sale of income tax net operating losses	`FundsReceivedFromSaleOfIncomeTaxNetOperatingLosses`	$685.00K	USD	Point-in-time
Funds received from sale of income tax net operating losses	`FundsReceivedFromSaleOfIncomeTaxNetOperatingLosses`	$686.00K	USD	1 Quarter
Redeemable warrants valuation adjustment	`DerivativeGainOnDerivative`	$-151.00K	USD	1 Quarter
Redeemable warrants valuation adjustment	`DerivativeGainOnDerivative`	$89.00K	USD	1 Quarter
Net loss	`ProfitLoss`	$-2.31M	USD	1 Quarter
Net loss	`ProfitLoss`	$-3.61M	USD	1 Quarter
Unrealized gain on marketable securities	`UnrealizedGainLossOnInvestments`	$397.00K	USD	1 Quarter
Unrealized gain on marketable securities	`UnrealizedGainLossOnInvestments`	$45.00K	USD	1 Quarter
Realized loss on securities	`OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax`	$-10.00K	USD	1 Quarter
Realized loss on securities	`OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax`	$-16.00K	USD	1 Quarter
Less: Premium amortization	`OtherComprehensiveIncomeLossReclassificationAdjustmentForWritedownOfSecuritiesIncludedInNetIncomeNetOfTax`	$60.00K	USD	1 Quarter
Less: Premium amortization	`OtherComprehensiveIncomeLossReclassificationAdjustmentForWritedownOfSecuritiesIncludedInNetIncomeNetOfTax`	$1.00K	USD	1 Quarter
Net comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-3.58M	USD	1 Quarter
Net comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-1.87M	USD	1 Quarter
Basic and diluted loss per share (usd per share)	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	1 Quarter
Basic and diluted loss per share (usd per share)	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	1 Quarter
Weighted average shares outstanding, basic and diluted (shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	166.81M	shares	1 Quarter
Weighted average shares outstanding, basic and diluted (shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	135.79M	shares	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.